| mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
-0.046 |
0.9 |
| mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
-0.0069 |
0.9 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0063 |
0.9 |
| mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.9 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |
| mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
0.044 |
0.9 |
| mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |
| mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |
| mRNA |
SGX-523 |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |